Nansha, Guangdong, ChinaFounded 201931+ employeesPrivate
$110M raisedSeries A· last: series a (Sep 2021)· 2 rounds
Backed by(10 investors)
Gaorong Capital · Lead+9 more
Guangzhou Yinming Biomedical Technology Co., Ltd. is a platform-based enterprise guided by First-in-Class pharmaceutical innovation. Yinming Bio has a research and development team composed of many top scientists and experts and a scientific committee composed of scientists with global influence.
